EDCTP- European and Developing Countries Clinical Trials Partnership

The Global Health European and Developing Countries Clinical Trials Joint Undertaking (GH EDCTP3 JU, 2021-2031) is a partnership between the European Union and Africa in global health.

GH EDCTP3 JU is the third EDCTP programme and is an institutionalized Article 187 partnership that builds on the success of the previous programmes, EDCTP 1 and EDCTP 2. GH EDCTP3 JU aims to contribute to the development of new or improved health technologies for the identification, treatment and prevention of neglected and poverty-related infectious diseases, including (re)emerging diseases affecting sub-Saharan Africa.

In addition, GH EDCTP3 JU will fund activities to build capacity for research in Africa, supporting the careers of researchers and strengthening national health research systems, improving the capacity of sub-Saharan African countries to identify and respond to health challenges related to infectious diseases.

The general objectives of the GH EDCTP3 JU are:

Reduce the socio-economic impact of infectious diseases in sub-Saharan Africa by promoting the development and adoption of new or improved health technologies, and
Increase health security in sub-Saharan Africa and globally by strengthening preparedness and response capacity for infectious disease control, based on research and innovation.

The GH EDCTP3 JU has a total estimated budget of 1.6 billion euros. The financial contributions come from the EU (0.8 billion euros), the European and African members of EDCTP (0.43 billion euros) and contributing partners such as philanthropies or industry (0.4 billion euros). Portugal was a founding member of EDCTP and is also a member of the new GH EDCTP3 JU program, represented by FCT and AICIB.

The priority areas of GH EDCTP3 JU are described in the Strategic Research and Innovation Agenda.

For more information on the GH EDCTP3 JU, visit the GH EDCTP3 JU interim page.

Financing opportunities

GH EDCTP3 JU funding opportunities include, on an annual basis, the launch of joint transnational Calls for funding for clinical research proposals, capacity building and/or networking in EDCTP3 priority areas. Previous editions can be consulted at this link.

NOTE: The Lusophone Platform in Clinical Research and Biomedical Innovation, PLICIB, created by AICIB with the support of FCT and co-financed by EDCTP3, aims to be an effective support for the Portuguese scientific community, together with the scientific community in Portuguese-speaking African countries (PALOP) and neighboring countries, in order to be more competitive for GH EDCTP3 JU funding opportunities.

Past events

Webinar on GH EDCTP3 funding opportunities - part 1: March 23. Recording of the infoday and ppt presentation.
Webinar on GH EDCTP3 funding opportunities - part 2: April 12. Recording of the infoday.
National webinar on GH EDCTP3 JU funding opportunities organized by FCT and AICIB: 21 April, 10:30 (GMT). More information here.
EDCTP Forum: From November 7 to 10, 2023, the 11th EDCTP Forum, organized by France, will be held in Paris.
- Submission of abstracts for oral presentations or e-poster presentations of original contributions on global health research. Deadline: May 3rd
- Four prizes will be awarded to recognize outstanding individuals and research teams who have made significant achievements in their field. Deadline: May 31st
- More information here.

Future Events

The twelfth edition of the EDCTP Forum under the theme "Better health through global research partnerships" will take place in Kigali, Rwanda, from June 15 to 20, 2025, at the Kigali Convention Center. More information at this link.